IDO1 and cancer: Because SLC6A14 is a broad specific amino acid transporter that can also transfer Arg and its expression can be upregulated by IDO1 (by a mechanism not identified yet) (38), the “doors” for the cell entrance of Arg and Trp may represent suitable cancer drug targets capable of interfering with both ARG1 and IDO1 pathways (39).